Internal Medicine, Rheumatology · Denver, CO
NPI
1568456127
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
7111 E Lowry Blvd Ste 200
Denver, CO, 80230
Phone (303) 394-2828
Medicare paid, 2024
$1.4M
101,141 services
Medicare patients, 2024
522
Average age 74
Drug cost, 2024
$2.1M
4,132 prescriptions
Company payments, 2024
$101
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vance J Bray was code J3262 (injection, tocilizumab, 1 mg), 20,960 times for 11 patients. In total Vance J Bray billed 101,141 services in 78 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 20,960 | 11 | $4.72 | $99K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 19,650 | 38 | $9.14 | $180K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,825 | 43 | $33.90 | $367K |
| J0897 Injection, denosumab, 1 mg | Office | 10,440 | 125 | $20.31 | $212K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 3,990 | 11 | $8.56 | $34K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,680 | 51 | $0.10 | $369 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,450 | 26 | $24.03 | $83K |
| J9312 Injection, rituximab, 10 mg | Office | 2,900 | 11 | $61.27 | $178K |
| 99214 Office E&M - Established | Office | 625 | 337 | $94.81 | $59K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 612 | 16 | $0.23 | $140 |
| 96413 Chemotherapy Administration | Office | 415 | 134 | $103.26 | $43K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 401 | 126 | $0.51 | $203 |
| 96401 Chemotherapy Administration | Office | 312 | 141 | $55.05 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 304 | 217 | $12.45 | $3,783 |
| 36415 Venipuncture Blood Collection | Office | 211 | 102 | $8.62 | $1,819 |
By year: 2022 $1.5M for 94,216 services; 2023 $1.5M for 96,585 services; 2024 $1.4M for 101,141 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 211 | 102 | $8.62 | $1,819 |
Medicare prescription drug claims, 2024
In 2024, the drug Vance J Bray prescribed most often to Medicare patients was Prednisone, with 549 prescriptions and refills. In total Vance J Bray wrote 4,132 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 549 | 890 | 147 | $4,394 |
| Hydroxychloroquine Sulfate Generic | 392 | 1,000 | 108 | $17K |
| Tramadol Hcl Generic | 309 | 329 | 94 | $4,517 |
| Celecoxib Generic | 291 | 623 | 84 | $9,816 |
| Methotrexate Methotrexate Sodium | 200 | 424 | 48 | $4,533 |
| Meloxicam Generic | 173 | 400 | 56 | $932 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 173 | 173 | 48 | $6,467 |
| Alendronate Sodium Generic | 133 | 351 | 48 | $1,032 |
| Leflunomide Generic | 128 | 287 | 32 | $5,537 |
| Methylprednisolone Generic | 116 | 158 | 56 | $1,513 |
| Sulfasalazine Dr Sulfasalazine | 99 | 187 | 27 | $5,300 |
| Gabapentin Generic | 85 | 163 | 19 | $1,155 |
| Diclofenac Sodium Generic | 71 | 150 | 32 | $7,907 |
| Duloxetine Hcl Generic | 68 | 160 | 16 | $1,891 |
| Allopurinol Generic | 67 | 196 | 20 | $841 |
Brand drugs: - claims; generic drugs: 3,693 claims; opioid claims: 595.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Vance J Bray $101 ($101 in general payments such as food, travel and fees) from 4 companies. The largest payer was GlaxoSmithKline, LLC. with $45.35.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.